JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

JNJ

227.55

+1.33%↑

ISRG

521.53

-0.83%↓

ABT

106.07

-1.49%↓

MDT

100.69

+0.19%↑

133.98

-1.27%↓

Kodu・Aktsiate loetelu・Clover Health Investments Corp

Clover Health Investments Corp

Avatud

2.3 -2.95

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.29

Max

2.38

Põhinäitajad
By Trading Economics
Sissetulek	-14M -24M
Müük	19M 497M
Kasumimarginaal	-4.908
Töötajad	570
EBITDA	-14M -24M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+56.78% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	26. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-600M 1.3B
Eelmine avamishind	5.25
Eelmine sulgemishind	2.3

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.4 / 3.77 Toetus ja vastupanu

Clover Health Investments Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. jaan 2026, 23:07 UTC

Tulu

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27. jaan 2026, 21:27 UTC

Tulu

Texas Instruments 4Q Sales Rise, Profit Falls

27. jaan 2026, 23:55 UTC

Market Talk

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27. jaan 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27. jaan 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27. jaan 2026, 23:39 UTC

Market Talk

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27. jaan 2026, 23:20 UTC

Tulu

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation Posts Net Loss for Second Consecutive Year

27. jaan 2026, 23:19 UTC

Tulu

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27. jaan 2026, 23:18 UTC

Tulu

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27. jaan 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

27. jaan 2026, 23:11 UTC

Market Talk

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27. jaan 2026, 23:07 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27. jaan 2026, 22:17 UTC

Market Talk

U.S. Dollar Slips Following Trump Comments -- Market Talk

27. jaan 2026, 22:06 UTC

Tulu

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27. jaan 2026, 21:51 UTC

Tulu

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. jaan 2026, 21:43 UTC

Tulu

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27. jaan 2026, 21:41 UTC

Tulu

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27. jaan 2026, 21:38 UTC

Tulu

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27. jaan 2026, 21:32 UTC

Tulu

Ampol: Modest Profit From F&I International in 2025

27. jaan 2026, 21:32 UTC

Tulu

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27. jaan 2026, 21:31 UTC

Tulu

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27. jaan 2026, 21:31 UTC

Tulu

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27. jaan 2026, 21:30 UTC

Tulu

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27. jaan 2026, 21:29 UTC

Tulu

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27. jaan 2026, 21:28 UTC

Tulu

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Võrdlus sarnastega

Hinnamuutus

Clover Health Investments Corp Prognoos

Hinnasiht

By TipRanks

56.78% tõus

12 kuu keskmine prognoos

Keskmine 3.7 USD 56.78%

Kõrge 3.7 USD

Madal 3.7 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Clover Health Investments Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Clover Health Investments Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.4 / 3.77Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.